title: Advances in cranioplasty with osteoinductive biomaterials: summary of experimental studies and clinical prospects.
abstract: The surgical repair of large calvarial defects is still a challenge for craniofacial surgeons. Since the discovery of bone growth factors, numerous studies have confirmed the interest of osteoinduction for bone repair. We summarize the findings of experimental and clinical trials carried out with composite bone substitutes. The triple mixture of TGF-beta 1, fibrin glue, and natural coral has proven effective in repairing rabbit skull defects. The same preparation was also efficient for a cranioplasty in two of three patients, age being a limiting factor. The adjunction of bone morphogenetic protein to autologous bone marrow was shown to be a potentiating factor in a rat cranioplasty model, but the combination of fibrin glue and bone marrow on a natural coral carrier was unable to achieve bone repair in children aged 6 years. Although the series were limited, stability and asepsis were important factors in promoting bony ingrowth. Cranioplasties with osteogenic biomaterials may be good option, but the most adequate dose of growth factor should be determined.
authors.affiliation: Craniofacial Unit, Department of Neurosurgery, Hôpital Necker-Enfants-Malades, Paris, France. ericarnaud@compuserve.com
authors.forename: E
authors.initials: E
authors.lastname: Arnaud
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D016026:Bone Marrow Transplantation; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage; D018786:Bone Substitutes; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003063:Cnidaria; D003399:Craniotomy / Q000379:methods*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016348:Osseointegration / Q000187:drug effects / Q000502:physiology*; D011817:Rabbits; D051381:Rats; D016212:Transforming Growth Factor beta / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D019485:Bone Morphogenetic Proteins; D018786:Bone Substitutes; D015718:Fibrin Tissue Adhesive; D016212:Transforming Growth Factor beta